Showing 1 - 4 results of 4 for search 'Kiran Kumar Rathinam', query time: 0.03s Refine Results
  1. 1
    Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review

    Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review by Kiran Kumar Rathinam, PharmD, Justin Jacob Abraham, PharmD, Thangavel Mahalingam Vijayakumar, PhD

    Published 2019-01-01
    Get full text
    Article
  2. 2
    Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19

    Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19 by I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Justin Jacob Abraham, Muhasaparur Ganesan Rajanandh, Thangavel Mahalingam Vijayakumar

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19

    Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19 by Justin Jacob Abraham, I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Muhasaparur Ganesan Rajanandh, Vijayakumar Thangavel Mahalingam

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial

    Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial by Karthickeyan Krishnan, Muthuraj K, Nandhini K, Yalamanchili Dharma Teja, Vikrama Simha Reddy, Neethu Sara Raju, Kiran Kumar Rathinam

    Published 2021-09-01
    Get full text
    Article

Search Tools: